Clinical Trial: A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Diabetic Peripheral Neuropathy
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Brief Summary:
The main purpose of this study is to determine the safety and efficacy of LY3556050 versus placebo in participants with diabetic peripheral neuropathic pain (DPNP).The study will lasts approximately 24 weeks, across 3 study periods.
Read more